miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes have?
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes has 357 citations in the OpenAlex counts ScholarIQ stores.
When was miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes published?
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes has 2013 year in the ScholarIQ index.
What is the open-access status of miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes?
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes?
The DOI for miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes is on the source record.
What is the PMID of miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes?
The PMID for miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes is on the source record.
What is the OpenAlex record for miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes?
The OpenAlex for miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes is on the source record.